Family of 29-year-old entrepreneur claim the NHS is 'inhumane' for denying him cannabis oil

George Gannon, 29, was diagnosed while living in Thailand. On return the UK in 2018, he was told his cancer was terminal. His family believes a prescription could 'save his life'.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

ConclusionLocal thermal ablation for the oligoprogressive lesions with continuous EGFR-TKI treatment is associated with additional 10  months of disease control and should be recommended in TKI acquired resistant-NSCLC patients.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
No abstract available
Source: Postgraduate Obstetrics and Gynecology - Category: OBGYN Tags: Article Source Type: research
Abstract New Pd(II) and Pt(IV) triazine complexes [Pt3(L 1 )2(Cl)9(H2O)3].3Cl.3H2O (1), [Pt3(L 2 )2(Cl)9(H2O)3].3Cl (2), [Pt3(L 3 )2(Cl)9(H2O)3].3Cl (3), [Pt2(L 4 )2(Cl)6(H2O)2] .2Cl.4H2O (4), [Pd3(L 1 )2(H2O)6] .3Cl2 (5), [Pd3(L 2 )2(H2O)6].3Cl2 (6), [Pd3(L 3 )2(H2O)6].3Cl2 (7), and [Pd2(L 4 )2(H2O)4].2Cl2 (8) were synthesized and well characterized using elemental analyses, molar conductance, IR, UV-Vis, magnetic susceptibility, 1H, 13C-NMR spectra, and thermal analyses. These analyses deduced that the L 1 , L 2 , and L 3 ligands act as tridentate forming octahedral geometry with Pt(IV) metal ions and square pla...
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
Blockage of TGF-α Induced by Spherical Silica Nanoparticles Inhibits Epithelial-Mesenchymal Transition and Proliferation of Human Lung Epithelial Cells. Biomed Res Int. 2019;2019:8231267 Authors: Li Y, Li H, Duan Y, Cai X, You D, Zhou F, Yang C, Tuo X, Liu Z Abstract Background. Xuanwei City in Yunnan province has been one of the towns with highest lung cancer mortality in China. The high content of amorphous silica in the bituminous coal from Xuanwei of Yunnan is mainly present as irregular and spherical silica nanoparticles (SiNPs). It has been reported that silica nanoparticles in bituminous ...
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
ConclusionSpNQ-Ch-27 is applicable for Chinese cancer patients with better validity and higher internal consistency, and it can be used as a tool to assess the spiritual needs of cancer patients.
Source: International Journal of Nursing Sciences - Category: Nursing Source Type: research
SAN FRANCISCO - Phase 2 of the federal bellwether glyphosate cancer trial in California started March 20, after a jury the first phase found that the chemical, which is the active ingredient in Monsanto Co.'s herbicide Roundup, was "a substantial factor" in causing the plaintiff's non-Hodgkin lymphoma (NHL) (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SAN FRANCISCO - A jury in a federal bellwether glyphosate cancer trial in California on March 19 found that the chemical, which is the active ingredient in Monsanto Co.'s herbicide Roundup, was "a substantial factor" in causing the plaintiff's non-Hodgkin lymphoma. Phase 2 of the trial, to determine liability and damages, is slated to begin March 20 (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SAN FRANCISCO - The attorneys representing the plaintiff and Monsanto Co. in the bellwether federal glyphosate cancer trial presented closing arguments on March 12 for Phase 1 of the trial, which deals with the sole issue of causation (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SAN FRANCISCO - Monsanto Co. on March 4 filed a brief in California federal court contending that in the bellwether glyphosate cancer trial, the plaintiff's supplemental brief regarding alleged fraud at a laboratory that tested the chemical "misrepresents the historical record" and "has no relevance to any of the issues" in the trial's second phase (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SAN FRANCISCO - The California federal judge presiding over the bellwether glyphosate cancer trial against Monsanto Co. on March 13 denied the company's motion for a directed verdict on causation (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
More News: Cancer | Cancer & Oncology | Health | Thailand Health